DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 126 filers reported holding DYNE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,788 | +16.9% | 79,063 | -5.8% | 0.00% | 0.0% |
Q1 2024 | $2,384 | +16.9% | 83,972 | -45.2% | 0.00% | 0.0% |
Q4 2023 | $2,039 | +128.6% | 153,351 | +54.0% | 0.00% | 0.0% |
Q3 2023 | $892 | -3.3% | 99,574 | +21.5% | 0.00% | 0.0% |
Q2 2023 | $922 | +149.2% | 81,971 | +155.5% | 0.00% | – |
Q1 2023 | $370 | +31.2% | 32,088 | +32.4% | 0.00% | – |
Q4 2022 | $282 | -99.9% | 24,243 | +41.9% | 0.00% | – |
Q3 2022 | $217,000 | -60.3% | 17,079 | -78.5% | 0.00% | – |
Q2 2022 | $547,000 | +195.7% | 79,499 | +314.4% | 0.00% | – |
Q1 2022 | $185,000 | – | 19,186 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |